ADIPOQ and fatty liver disease: Nevertheless, adiponectin is causally linked to obesity-related steatosis by knockout and transgenic models (Kim et al. 2007, Liu et al. 2012), the latter demonstrating that overexpression of adiponectin can prevent liver steatosis despite marked obesity.